SEC Form 4 · accession 0001493152-26-027259
Lipocine Inc. · LPCN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Dana Ono
Director
Period of report
Jun 3, 2026
Accepted (ET)
Jun 4, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001535955
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Right to Buy)F1 | $2.19 | Jun 3, 2026 | A | 1,764 | A | Jun 3, 2027 | Jun 3, 2036 | Common Stock | 1,764 | 13,290 | D |
Explanation of responses
- F1100% vesting one year from date of grant.